23 May 2013
Keywords: abbott, licenses, ono, cancer, drug, laboratories, signed
Article | 07 July 2000
Abbott Laboratories has signed a licensing agreement for OnoPharmaceuticals' E7010, which is currently in Phase I development for
the treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 July 2000
10 July 2000
3 July 2000
© 2013 thepharmaletter.com